MSF Access Campaign (@msf_access) 's Twitter Profile
MSF Access Campaign

@msf_access

We advocate for access to & development of lifesaving medicines, tests & vaccines for people in MSF programmes & beyond. #MedicinesShouldntBeALuxury

ID: 39773339

linkhttp://www.msfaccess.org calendar_today13-05-2009 15:34:16

15,15K Tweet

25,25K Takipçi

1,1K Takip Edilen

Partners In Health (@pih) 's Twitter Profile Photo

Major advance in the fight against #TB 🚨: Today, the World Health Organization (WHO) recommended four new, shorter, and more effective treatment regimens for curing drug-resistant TB. These treatments were studied in the endTB trial, led by PIH, MSF International & IRD Global. Read more: pih.org/press/major-ad…

MSF Access Campaign (@msf_access) 's Twitter Profile Photo

We co-authored this article calling for better access to long-acting antiretroviral meds for #HIV treatment & prevention. Current drugs are under the firm control of pharma corporations & unavailable or cost-prohibitive for people in much of the world.

MSF Access Campaign (@msf_access) 's Twitter Profile Photo

Sign this petition calling on Gilead Sciences to make the #HIV drug #lenacapavir accessible for people in low- & middle-income countries. Right now it's sold in high-income countries for treatment at $42,000/yr! But generics could be made for just $40. ✍️ secure.avaaz.org/campaign/en/en…

Winnie Byanyima (@winnie_byanyima) 's Twitter Profile Photo

New technologies are transforming health care, including for people living with HIV - including long-acting prevention and treatment medicines. These must be affordable and available as a global public good - now! sciencedirect.com/science/articl…

New technologies are transforming health care, including for people living with HIV - including long-acting prevention and treatment medicines. These must be affordable and available as a global public good - now!
sciencedirect.com/science/articl…
MSF Access Campaign (@msf_access) 's Twitter Profile Photo

Liposomal amphotericin B (LAmB) is a lifesaving medicine for many infectious diseases, but people in low- & middle-income countries lack access to it. MSF's Jessica Burry, @dndi & others address the access barriers in this The Lancet Global Health article. msfaccess.org/lancet-global-…

MSF Access Campaign (@msf_access) 's Twitter Profile Photo

We & CSOs call on Gavi, the Vaccine Alliance & UNICEF to ensure affordable pricing of the #mpox vaccine + support ‌Africa CDC's outbreak response coordination efforts in procuring & distributing vaccines doses - affordably, equitably & transparently. msfaccess.org/letter-csos-ca…

Health Justice Initiative - HJI (@healthjusticein) 's Twitter Profile Photo

🚨 Must Read 🚨 MSF Access Campaign & HJI write about the groundbreaking CompComSA investigation on a key TB DRUG in 2023 (BDQ) -that led to evergreening patents AND price being dropped, benefiting not just SA. 📲 spotlightnsp.co.za/2024/08/30/com… Via Spotlight Treatment Action Group (TAG) Stop TB Partnership

MSF Access Campaign (@msf_access) 's Twitter Profile Photo

Lifesaving tests can only save lives when they’re accessible! Sign the petition asking Cepheid & Danaher Corporation to drop the price of GeneXpert tests for all diseases so more lives can be saved. Your voice matters! #TimeFor5 🖊️timefor5.msfaccess.org

Lifesaving tests can only save lives when they’re accessible! 

Sign the petition asking <a href="/CepheidNews/">Cepheid</a> &amp; <a href="/DanaherCorp/">Danaher Corporation</a> to drop the price of GeneXpert tests for all diseases so more lives can be saved. Your voice matters! #TimeFor5

🖊️timefor5.msfaccess.org
🐢🐢🐢John Green🐢🐢🐢 (@johngreen) 's Twitter Profile Photo

Why does Danaher Corporation refuse to release the GeneXpert audit they promised to make public? Is it because tests cost less than they claim? Is it because they're just dilly-dallying while 100,000 people die of TB every MONTH? Regardless, it's unacceptable. msfaccess.org/hidden-costs-g…

Shailly Gupta (@shaillytweeting) 's Twitter Profile Photo

BIG news from India: People with drug-resistant TB can now access BPaLM i.e. more efficacious, much shorter, all-oral and has less side effects. It will also ensure better adherence and ambulatory treatment for many. Congrats to everyone who finally made this happen!